182 related articles for article (PubMed ID: 18008147)
1. Differential immunosuppressive effect of indoleamine 2,3-dioxygenase (IDO) on primary human CD4+ and CD8+ T cells.
Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
Mol Cell Biochem; 2008 Feb; 309(1-2):1-7. PubMed ID: 18008147
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2,3-dioxygenase depletes tryptophan, activates general control non-derepressible 2 kinase and down-regulates key enzymes involved in fatty acid synthesis in primary human CD4+ T cells.
Eleftheriadis T; Pissas G; Antoniadi G; Liakopoulos V; Stefanidis I
Immunology; 2015 Oct; 146(2):292-300. PubMed ID: 26147366
[TBL] [Abstract][Full Text] [Related]
3. Human primary CD4 + T cells activated in the presence of IFN-alpha 2b express functional indoleamine 2,3-dioxygenase.
Curreli S; Romerio F; Mirandola P; Barion P; Bemis K; Zella D
J Interferon Cytokine Res; 2001 Jun; 21(6):431-7. PubMed ID: 11440641
[TBL] [Abstract][Full Text] [Related]
4. Regulation of indoleamine 2,3-dioxygenase and tryptophanyl-tRNA-synthetase by CTLA-4-Fc in human CD4+ T cells.
Boasso A; Herbeuval JP; Hardy AW; Winkler C; Shearer GM
Blood; 2005 Feb; 105(4):1574-81. PubMed ID: 15466932
[TBL] [Abstract][Full Text] [Related]
5. High expression of IMPACT protein promotes resistance to indoleamine 2,3-dioxygenase-induced cell death.
Habibi D; Jalili RB; Forouzandeh F; Ong CJ; Ghahary A
J Cell Physiol; 2010 Oct; 225(1):196-205. PubMed ID: 20648630
[TBL] [Abstract][Full Text] [Related]
6. HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells.
Boasso A; Herbeuval JP; Hardy AW; Anderson SA; Dolan MJ; Fuchs D; Shearer GM
Blood; 2007 Apr; 109(8):3351-9. PubMed ID: 17158233
[TBL] [Abstract][Full Text] [Related]
7. Indoleamine 2,3-dioxygenase, by degrading L-tryptophan, enhances carnitine palmitoyltransferase I activity and fatty acid oxidation, and exerts fatty acid-dependent effects in human alloreactive CD4+ T-cells.
Eleftheriadis T; Pissas G; Sounidaki M; Tsogka K; Antoniadis N; Antoniadi G; Liakopoulos V; Stefanidis I
Int J Mol Med; 2016 Nov; 38(5):1605-1613. PubMed ID: 27667153
[TBL] [Abstract][Full Text] [Related]
8. Human renal tubular epithelial cells suppress alloreactive T cell proliferation.
Demmers MW; Korevaar SS; Roemeling-van Rhijn M; van den Bosch TP; Hoogduijn MJ; Betjes MG; Weimar W; Baan CC; Rowshani AT
Clin Exp Immunol; 2015 Mar; 179(3):509-19. PubMed ID: 25310899
[TBL] [Abstract][Full Text] [Related]
9. Suppression of immunodominant antitumor and antiviral CD8+ T cell responses by indoleamine 2,3-dioxygenase.
Rytelewski M; Meilleur CE; Yekta MA; Szabo PA; Garg N; Schell TD; Jevnikar AM; Sharif S; Singh B; Haeryfar SM
PLoS One; 2014; 9(2):e90439. PubMed ID: 24587363
[TBL] [Abstract][Full Text] [Related]
10. Ligation of B7-1/B7-2 by human CD4+ T cells triggers indoleamine 2,3-dioxygenase activity in dendritic cells.
Munn DH; Sharma MD; Mellor AL
J Immunol; 2004 Apr; 172(7):4100-10. PubMed ID: 15034022
[TBL] [Abstract][Full Text] [Related]
11. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
12. Indoleamine 2,3-dioxygenase mediates inhibition of virus-specific CD8(+) T cell proliferation by human mesenchymal stromal cells.
Hong J; Hueckelhoven A; Wang L; Schmitt A; Wuchter P; Tabarkiewicz J; Kleist C; Bieback K; Ho AD; Schmitt M
Cytotherapy; 2016 May; 18(5):621-9. PubMed ID: 27008974
[TBL] [Abstract][Full Text] [Related]
13. IDO expressing fibroblasts promote the expansion of antigen specific regulatory T cells.
Curran TA; Jalili RB; Farrokhi A; Ghahary A
Immunobiology; 2014 Jan; 219(1):17-24. PubMed ID: 23891282
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of levo-1-methyl tryptophan and dextro-1-methyl tryptophan in reversing indoleamine-2,3-dioxygenase-mediated arrest of T-cell proliferation in human epithelial ovarian cancer.
Qian F; Villella J; Wallace PK; Mhawech-Fauceglia P; Tario JD; Andrews C; Matsuzaki J; Valmori D; Ayyoub M; Frederick PJ; Beck A; Liao J; Cheney R; Moysich K; Lele S; Shrikant P; Old LJ; Odunsi K
Cancer Res; 2009 Jul; 69(13):5498-504. PubMed ID: 19491279
[TBL] [Abstract][Full Text] [Related]
15. IDO decreases glycolysis and glutaminolysis by activating GCN2K, while it increases fatty acid oxidation by activating AhR, thus preserving CD4+ T‑cell survival and proliferation.
Eleftheriadis T; Pissas G; Liakopoulos V; Stefanidis I
Int J Mol Med; 2018 Jul; 42(1):557-568. PubMed ID: 29693118
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of indoleamine 2,3-dioxygenase enhances the T-cell response to influenza virus infection.
Fox JM; Sage LK; Huang L; Barber J; Klonowski KD; Mellor AL; Tompkins SM; Tripp RA
J Gen Virol; 2013 Jul; 94(Pt 7):1451-1461. PubMed ID: 23580425
[TBL] [Abstract][Full Text] [Related]
17. Skin cells, but not T cells, are resistant to indoleamine 2, 3-dioxygenase (IDO) expressed by allogeneic fibroblasts.
Forouzandeh F; Jalili RB; Germain M; Duronio V; Ghahary A
Wound Repair Regen; 2008; 16(3):379-87. PubMed ID: 18471256
[TBL] [Abstract][Full Text] [Related]
18. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG).
Sarkhosh K; Tredget EE; Karami A; Uludag H; Iwashina T; Kilani RT; Ghahary A
J Cell Biochem; 2003 Sep; 90(1):206-17. PubMed ID: 12938169
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase increases p53 levels in alloreactive human T cells, and both indoleamine 2,3-dioxygenase and p53 suppress glucose uptake, glycolysis and proliferation.
Eleftheriadis T; Pissas G; Antoniadi G; Spanoulis A; Liakopoulos V; Stefanidis I
Int Immunol; 2014 Dec; 26(12):673-84. PubMed ID: 25064493
[TBL] [Abstract][Full Text] [Related]
20. Immuno-regulatory function of indoleamine 2,3 dioxygenase through modulation of innate immune responses.
Poormasjedi-Meibod MS; Jalili RB; Hosseini-Tabatabaei A; Hartwell R; Ghahary A
PLoS One; 2013; 8(8):e71044. PubMed ID: 23940687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
